Chemsi M1, Hamid H1*, Houari S1, Zerouali K2, Lehlimi M1, Ouhadous M3, Habzi A1 and Benomar S1
1Intensive Care Unit and Neonatal, Hospital of Children Abderrahim ELHarouchi- Casablanca, Morocco
2Bacteriology Laboratoire, Ibn Rochd Hospital-Casablanca, Morocco
3Committee against Nosocomial Infections, Morocco
Received Date: December 28, 2015; Accepted Date: November 21, 2016; Published Date: November 24, 2016
Citation: Chemsi M, Hamid H, Houari S, Zerouali K, Lehlimi M, et al. (2016) An Outbreak of Serratia marcescens on the Neonatal Unit: Description and Investigations. J Infect Dis Ther 4:306. doi: 10.4172/2332-0877.1000306
Copyright: © 2016 Chemsi M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Infectious Diseases & Therapy
In september 2013, an outbreak of Serratiamarcescens infection occured in the neonatal intensive care unit of children’s hospital Abderrahim Harrouchi in Casablanca. Rapid microbiological investigation lead to identify nine cases of S. marcescens sepsis.The environemental investigation didn’t detect S.marcescens. Strict hygiene measures were lead to early interruption of the outbreak, without reccurences to this date still.
Serratia marcescens; Neonatal infection; Outbreak
Serratia marcescens is an Enterobacteriaceae opportunistic gram negative, nosocomial pathogen [1].
Several outbreaks of Serratia marcescens in neonatal intensive care unit (NICU) were documented in recent years, causing potentially fatal sepsis, meningitis or pneumoniae in very premature or low birth weight neonates with mortality rates as high as 44% [2,3].
Normally, S. marcescens is not a part of the intestinal bacterial flora of neonates [4].
This bacterium may be transmitted to neonates through feeding, contaminated antiseptics and breast pumps and it can be spread via contact with patient [5].
The objective of this study is to identify the clinical and epidemiological characteristics of S. marcescens infections, and propose an urgent management strategy to control the outbreak.
Retrospective study of the cases of Serratiamarcescens outbreaks for a period of one month from September to October 2013 in newborns aged between 0-28days in neonatal unit of Abderrahim El Harrouchi’s hospital in Casablanca.
Nine cases of nosocomial infection of Serratia marcescens were registered (7 inborn and 2 out born). The breakdown by gender in our series shows: six girls and three boys, four of whom were premature, three newborn weighed less than 2000 g. The reason for hospitalization was respiratory distress in 8 cases and an anoxic ischemic encephalopathy in one case. Seven neonates were receiving antibiotics (3rd generation cephalosporins). The average time of onset of nosocomial infection was 5 days +/- 2,16.
The Clinical presentation was a septic shock in 5 cases, neurological signs in 2 newborn, a failure of extubation in 2 cases (Table 1), and biologically a significant increasing C-reactive protein (CRP) values in all cases.
Clinical presentation | Number of cases | percentage |
---|---|---|
Septic shock | 5 | 56% |
Neurological signs | 2 | 22% |
Failure of extubation | 2 | 22% |
Table 1: Clinical presentation of nosocomial infection of S. marcescens .
The bacteremia was found in all patients associated with two meningeal locations. Blood cultures in all cases grew S. marcescens fully susceptible to imipenem, amikacin and ciprofloxacin (Table 2). All our patients were treated with imipenem and amikacin in all cases and ciproxin in both case of meningeal location. Five neonates with clinical signs of sepsis died, leading to a mortality rate of 54%.
ANTIBIOTICS | RESULTS |
---|---|
Ampicillin | Resistant |
Amoxicillin/Acide clavulanic | Resistant |
Cefolatin | Resistant |
Ceftazidim | Sensible |
Aztreonam | Sensible |
Colistin | Intermediary |
Cefoxitin | Resistant |
Ertapenem | Sensible |
Amikacin | Sensible |
Ciprofloxacin | Sensible |
Imipenem | Sensible |
Cotrimoxazole | Sensible |
Table 2: Susceptibility to antibiotics of Serratia marcescens.
Some days after neonates became symptomatic, extensive environemental microbiological investigations started. Swabs were taken from numerous surfaces, including walls, floors with their edges and corners, doors and door handles, shelves, benches, hoods, sinks, cradles and ventilators, stethoscopes and other personal medical devices. No common point source was identified, strict hygiene mesures lead to early interruption of the outbreak, without recurrences to this date. (possible sources were disposed and renewed, including parenteral nutrition, disinfectants, soaps and soap dispensers, cotton and tissues, other hygienic measures were taken, such as hand washing with alcohol based solutions at all sites in the ward, and using gloves when assisting and caring for neonates) (Table 3).
Case | Sex | Gestational age (weeks) | Birth weight (g) | Invasive Procedures | Culture Results (Blood) | Culture Results (CSF) | Evaluation |
---|---|---|---|---|---|---|---|
1 | F | 37 | 3900 | Respiratory distress | S. marcescens | S. marcescens | Survived |
2 | M | 29 | 1250 | Respiratory distress | S. marcescens | (-) | Died |
3 | F | 40 | 3200 | Respiratory distress | S. marcescens | (-) | Died |
4 | M | 34 | 2500 | Respiratory distress | S. marcescens | (-) | Survived |
5 | M | 35 | 1550 | Respiratory distress | S. marcescens | (-) | Survived |
6 | F | 37 | 2300 | Respiratory distress | S. marcescens | (-) | Died |
7 | F | 39 | 3780 | Respiratory distress | S. marcescens | (-) | Died |
8 | F | 38 | 3600 | anoxicischemic encepalopathy | S. marcescens | S. marcescens | Died |
9 | F | 36 | 1750 | Respiratory distress | S. marcescens | (-) | Survived |
UVC: Umbilical Venous Catheter; PVC: Peripheral Venous Catheter; CSF: Cerebrospinal Fluid |
Table 3: Clinical characteristics and culture results of the nine infants infected with serratia marcescens.
Serratia marcescens is an important nosocomial pathogen, especially in neonatal intensive care units (NICU) 11-15%, and it may causes serious infections, including bacteremia (42%), pneumonia (13%), urinary tract infections (8%) and meningitis (7%), with significant morbidity and mortality rate among newborns (44%) [6,7].
Risk factors for acquisition of nosocomial infections in NICUs are low birth weight, long duration of hospitalization and receiving of critical care [8].
In an outbreak S. marcescens , extensive environmental microbiological investigations are needed to identify sources and reservoirs [2].
Previous publications have reported various sources of contamination such as breast pumps [5], plastic bottles used for umbilical irrigation [9], scalp vein needles [10], soap dispensers [11] or nail brushes [12], but no source was identified in our study.
Reported morbidity and mortality rates associated with S. marcescens outbreaks vary. During an outbreak in a French maternity hospital, only one newborn developed bacteremia and colonization was revealed in the stool samples obtained from 36 newborn [6].
In a report by Halle et al. [13], 27 infants in an NICU were involved in an outbreak, 14 of these infants developed septicemia and/or meningitis, 11 of whom died. In our study, we observed 5 cases of septicemia with fatal outcomes.
Under such circumstances, strict measures such as relocating nurses, closure of wards to new admissions and even temporary total closures of NICU were necessary to contain the spread of microorganism [7,14].
This report serves as reminder of the importance to keep up hygiene precautions at any time specifically in high risk settings such as a NICU.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals